3rd Quarter - Report

THE MCMANUS GROUP for ZIMMER BIOMET

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Support for H.R. 184 / S. 108 - Protection Medical Innovation Act of 2017. Support for Sec. 113 of S. ___ - Better Care Reconciliation Act of 2017.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 108 (115th), H.R. 184 (115th)

Health Issues HCR

Legislation and FDA regulation concerning medical device development, manufacturing, commercialization, and post-market regulation and activities. S. 404 - A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications. H.R. 2430/S.934 FDA Reauthorization Act of 2017.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 404 (115th), S. 934 (115th), H.R. 2430 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.